1050521-37-3

Basic information

• Product Name: N-((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)adamantane-1-carboxamide
• Synonyms: N-((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)adamantane-1-carboxamide
• CAS NO: 1050521-37-3
• Molecular Weight: 313.44
• Mol File: 1050521-37-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)adamantane-1-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)adamantane-1-carboxamide(1050521-37-3)
• EPA Substance Registry System: N-((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)adamantane-1-carboxamide(1050521-37-3)

Safety Data

• Hazardous Substances Data: 1050521-37-3(Hazardous Substances Data)

Upstream product

• 828-51-3 1-Adamantanecarboxylic acid 
• 37577-28-9 (1S,2R)-(+)-norphedrine 
• 2094-72-6 1-Adamantanecarbonyl chloride 

Downstream Products

• 1050521-39-5 (1S,2R)-2-(1-adamantylmethylamino)-1-phenylpropan-1-ol 
• 1050521-35-1 (4R,5S)-3-((1-adamantyl)methyl)-4-methyl-5-phenyloxazolidin-2-one 

Relevant articles and documents

CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1

This invention relates to novel compounds of the Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 beta-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of Cortisol in a cell or the inhibition of the conversion of cortisone to Cortisol in a cell.